newsfilter
← Latest News
PR Newswire·

NeuroBo to Participate in Investor Conferences in December

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today ...